# pathway_0078: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0078.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Capsule biogenesis

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MVKKILIVFGTRPEAIKMAPLVKIMENRNDVNFRVCVTGQHRQMLDQILNIFDIKPDYDLNIMQENQDLYDITLKILCGMKNVLNDFKPNIVLVHGDTTTASVTALAAFYQKIKIAHVEAGLRTYNICNPWPEEANRQIIGVLANIHFTPTVKSAENLIKEGKNKEGIFITGNTVIDALFYMTEKIKNDKTFKIKVLSSIGNEYKINDNKKFILVTGHRRENFGEGFLQICEALKIIAINNPDIDIVYPVHLNPNVQKPVKMLLLNISNIYLINPLKYEEFIYLMSKSYFIITDSGGIQEEAPSLGKPILVMRETTERPEAVEAGVVKLVGACKQNIIRESQKLIDDQDEYEKMSKAYNPYGDGRACEKIINILIKGKNNESI

[Multiple Choices]
A. protein ubiquitination. .
B. Capsule biogenesis
C. ajmaline biosynthesis. .
D. iron-sulfur cluster biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the Campylobacter jejuni UniProt entry annotated for capsule biogenesis and capsule polysaccharide biosynthesis. That pathway annotation cites a 2024 paper and carries an experimental-evidence code; the excerpts support the key, though they do not independently establish the paper’s experimental results.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may support identifying an enzyme family, but the input gives no organism, pathway context, or experimentally established role. Inferring which pathway this particular enzyme serves requires a protein-specific functional annotation or equivalent knowledge.


**Missing item-specific fact**

> The sequence-matched protein is annotated as UDP-N-acetylglucosamine 2-epimerase functioning in capsule polysaccharide biosynthesis.


**Reason**

> The reviewer-only annotation supports the key but was absent from the evaluated input. Recognizing the sequence or recalling its database entry would be lookup or memorization, not reasoning from the supplied information.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The choices are distinct, and the matched-entry pathway annotation supports B. The supplied input alone does not identify the pathway, but the reviewer evidence does not support another listed option.


### Important caveats

- The sequence match is exact and applies to the 383-residue sequence.
- The annotated pathway is linked to a cited publication with an experimental-evidence code; the excerpts do not include the primary experimental results.
- The actual author source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may support identifying an enzyme family, but the input gives no organism, pathway context, or experimentally established role. Inferring which pathway this particular enzyme serves requires a protein-specific functional annotation or equivalent knowledge.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The sequence-matched protein is annotated as UDP-N-acetylglucosamine 2-epimerase functioning in capsule polysaccharide biosynthesis.",
    "reason": "The reviewer-only annotation supports the key but was absent from the evaluated input. Recognizing the sequence or recalling its database entry would be lookup or memorization, not reasoning from the supplied information."
  },
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the Campylobacter jejuni UniProt entry annotated for capsule biogenesis and capsule polysaccharide biosynthesis. That pathway annotation cites a 2024 paper and carries an experimental-evidence code; the excerpts support the key, though they do not independently establish the paper’s experimental results."
  },
  "important_caveats": [
    "The sequence match is exact and applies to the 383-residue sequence.",
    "The annotated pathway is linked to a cited publication with an experimental-evidence code; the excerpts do not include the primary experimental results.",
    "The actual author source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices are distinct, and the matched-entry pathway annotation supports B. The supplied input alone does not identify the pathway, but the reviewer evidence does not support another listed option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the Campylobacter jejuni UniProt entry annotated for capsule biogenesis and capsule polysaccharide biosynthesis. That pathway annotation cites a 2024 paper and carries an experimental-evidence code; the excerpts support the key, though they do not independently establish the paper’s experimental results.",
    "evidence_ids": ["C1", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may support identifying an enzyme family, but the input gives no organism, pathway context, or experimentally established role. Inferring which pathway this particular enzyme serves requires a protein-specific functional annotation or equivalent knowledge.",
    "missing_item_specific_fact": "The sequence-matched protein is annotated as UDP-N-acetylglucosamine 2-epimerase functioning in capsule polysaccharide biosynthesis.",
    "reason": "The reviewer-only annotation supports the key but was absent from the evaluated input. Recognizing the sequence or recalling its database entry would be lookup or memorization, not reasoning from the supplied information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices are distinct, and the matched-entry pathway annotation supports B. The supplied input alone does not identify the pathway, but the reviewer evidence does not support another listed option."
  },
  "important_caveats": [
    "The sequence match is exact and applies to the 383-residue sequence.",
    "The annotated pathway is linked to a cited publication with an experimental-evidence code; the excerpts do not include the primary experimental results.",
    "The actual author source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A0U3CEN8 (UAGEP_CAMJU) is annotated with PATHWAY: 'Capsule biogenesis; capsule polysaccharide biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed:38382015 (Ghosh & Raushel, Biochemistry 2024). The protein is UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14) from Campylobacter jejuni, experimentally shown to produce UDP-ManNAcA and CMP-Neu5Ac for capsular polysaccharides. Sequence match is exact (SHA256 confirmed).

Citations as saved: [C1](#evidence-c1), [C3](#evidence-c3), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains NAD-binding Rossmann-fold motifs (e.g., 'GDTTTAS') characteristic of sugar-processing epimerases/dehydratases, identifying it as a UDP-sugar-processing enzyme in a bacterium. Among the four choices: (A) protein ubiquitination is a eukaryotic-specific process absent in bacteria; (C) ajmaline biosynthesis is a plant-specific monoterpene indole alkaloid pathway; (D) iron-sulfur cluster biosynthesis involves cysteine desulfurases, scaffold proteins, and Fe-S ligases—entirely different enzyme classes with no NAD-dependent epimerase architecture. Only (B) capsule biogenesis is consistent with a bacterial UDP-sugar-processing enzyme involved in surface polysaccharide assembly. Elimination of the three clearly incompatible options leaves B as the sole biologically coherent choice.


**Missing item-specific fact**

> Positive identification that UDP-GlcNAc 2-epimerase specifically feeds into capsule polysaccharide biosynthesis in Campylobacter (as opposed to peptidoglycan, LPS, or other glycan pathways) requires organism-specific metabolic knowledge. However, this specificity is not needed to eliminate the three distractors, which are categorically incompatible with a bacterial NAD-dependent sugar epimerase.


**Reason**

> While the strongest positive identification of 'capsule biogenesis' benefits from knowing the organism and its specific metabolic network, the provided distractors are all categorically incompatible with a bacterial UDP-sugar epimerase. A model can reason through elimination using general biology: ubiquitination is eukaryotic, ajmaline is a plant alkaloid, and Fe-S cluster machinery is structurally unrelated. This provides meaningful, concrete biological grounds to select B without memorizing the exact database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, C, and D are categorically incompatible with a bacterial NAD-dependent UDP-sugar epimerase. No reasonable biological argument supports selecting them over B. The question is unambiguous among the given choices.


### Important caveats

- The positive pathway assignment (capsule vs. other glycan pathways like peptidoglycan or LPS) is organism-specific and would require knowledge of Campylobacter metabolism if the distractors included other glycan-related pathways.
- The UniProt annotation is based on experimental evidence (ECO:0000269) from a 2024 Biochemistry paper, not merely computational transfer.
- The firstPublicDate of the UniProt entry is 2025-06-18, meaning this annotation may not have been available at the time the benchmark was constructed; the underlying experimental paper (2024) predates the entry but the curated annotation is recent.
- The reasoning path is primarily eliminative rather than a direct positive identification from sequence features to 'capsule biogenesis' specifically.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains NAD-binding Rossmann-fold motifs (e.g., 'GDTTTAS') characteristic of sugar-processing epimerases/dehydratases, identifying it as a UDP-sugar-processing enzyme in a bacterium. Among the four choices: (A) protein ubiquitination is a eukaryotic-specific process absent in bacteria; (C) ajmaline biosynthesis is a plant-specific monoterpene indole alkaloid pathway; (D) iron-sulfur cluster biosynthesis involves cysteine desulfurases, scaffold proteins, and Fe-S ligases—entirely different enzyme classes with no NAD-dependent epimerase architecture. Only (B) capsule biogenesis is consistent with a bacterial UDP-sugar-processing enzyme involved in surface polysaccharide assembly. Elimination of the three clearly incompatible options leaves B as the sole biologically coherent choice.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Positive identification that UDP-GlcNAc 2-epimerase specifically feeds into capsule polysaccharide biosynthesis in Campylobacter (as opposed to peptidoglycan, LPS, or other glycan pathways) requires organism-specific metabolic knowledge. However, this specificity is not needed to eliminate the three distractors, which are categorically incompatible with a bacterial NAD-dependent sugar epimerase.",
    "reason": "While the strongest positive identification of 'capsule biogenesis' benefits from knowing the organism and its specific metabolic network, the provided distractors are all categorically incompatible with a bacterial UDP-sugar epimerase. A model can reason through elimination using general biology: ubiquitination is eukaryotic, ajmaline is a plant alkaloid, and Fe-S cluster machinery is structurally unrelated. This provides meaningful, concrete biological grounds to select B without memorizing the exact database entry."
  },
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C3",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A0U3CEN8 (UAGEP_CAMJU) is annotated with PATHWAY: 'Capsule biogenesis; capsule polysaccharide biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed:38382015 (Ghosh & Raushel, Biochemistry 2024). The protein is UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14) from Campylobacter jejuni, experimentally shown to produce UDP-ManNAcA and CMP-Neu5Ac for capsular polysaccharides. Sequence match is exact (SHA256 confirmed)."
  },
  "important_caveats": [
    "The positive pathway assignment (capsule vs. other glycan pathways like peptidoglycan or LPS) is organism-specific and would require knowledge of Campylobacter metabolism if the distractors included other glycan-related pathways.",
    "The UniProt annotation is based on experimental evidence (ECO:0000269) from a 2024 Biochemistry paper, not merely computational transfer.",
    "The firstPublicDate of the UniProt entry is 2025-06-18, meaning this annotation may not have been available at the time the benchmark was constructed; the underlying experimental paper (2024) predates the entry but the curated annotation is recent.",
    "The reasoning path is primarily eliminative rather than a direct positive identification from sequence features to 'capsule biogenesis' specifically."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are categorically incompatible with a bacterial NAD-dependent UDP-sugar epimerase. No reasonable biological argument supports selecting them over B. The question is unambiguous among the given choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A0U3CEN8 (UAGEP_CAMJU) is annotated with PATHWAY: 'Capsule biogenesis; capsule polysaccharide biosynthesis' with evidence code ECO:0000269 (direct assay) from PubMed:38382015 (Ghosh & Raushel, Biochemistry 2024). The protein is UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14) from Campylobacter jejuni, experimentally shown to produce UDP-ManNAcA and CMP-Neu5Ac for capsular polysaccharides. Sequence match is exact (SHA256 confirmed).",
    "evidence_ids": ["C1", "C3", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains NAD-binding Rossmann-fold motifs (e.g., 'GDTTTAS') characteristic of sugar-processing epimerases/dehydratases, identifying it as a UDP-sugar-processing enzyme in a bacterium. Among the four choices: (A) protein ubiquitination is a eukaryotic-specific process absent in bacteria; (C) ajmaline biosynthesis is a plant-specific monoterpene indole alkaloid pathway; (D) iron-sulfur cluster biosynthesis involves cysteine desulfurases, scaffold proteins, and Fe-S ligases—entirely different enzyme classes with no NAD-dependent epimerase architecture. Only (B) capsule biogenesis is consistent with a bacterial UDP-sugar-processing enzyme involved in surface polysaccharide assembly. Elimination of the three clearly incompatible options leaves B as the sole biologically coherent choice.",
    "missing_item_specific_fact": "Positive identification that UDP-GlcNAc 2-epimerase specifically feeds into capsule polysaccharide biosynthesis in Campylobacter (as opposed to peptidoglycan, LPS, or other glycan pathways) requires organism-specific metabolic knowledge. However, this specificity is not needed to eliminate the three distractors, which are categorically incompatible with a bacterial NAD-dependent sugar epimerase.",
    "reason": "While the strongest positive identification of 'capsule biogenesis' benefits from knowing the organism and its specific metabolic network, the provided distractors are all categorically incompatible with a bacterial UDP-sugar epimerase. A model can reason through elimination using general biology: ubiquitination is eukaryotic, ajmaline is a plant alkaloid, and Fe-S cluster machinery is structurally unrelated. This provides meaningful, concrete biological grounds to select B without memorizing the exact database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are categorically incompatible with a bacterial NAD-dependent UDP-sugar epimerase. No reasonable biological argument supports selecting them over B. The question is unambiguous among the given choices."
  },
  "important_caveats": [
    "The positive pathway assignment (capsule vs. other glycan pathways like peptidoglycan or LPS) is organism-specific and would require knowledge of Campylobacter metabolism if the distractors included other glycan-related pathways.",
    "The UniProt annotation is based on experimental evidence (ECO:0000269) from a 2024 Biochemistry paper, not merely computational transfer.",
    "The firstPublicDate of the UniProt entry is 2025-06-18, meaning this annotation may not have been available at the time the benchmark was constructed; the underlying experimental paper (2024) predates the entry but the curated annotation is recent.",
    "The reasoning path is primarily eliminative rather than a direct positive identification from sequence features to 'capsule biogenesis' specifically."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record identifies the protein as UDP-N-acetylglucosamine 2-epimerase and annotates its pathway as capsule biogenesis/capsule polysaccharide biosynthesis. The enzyme annotation and pathway claim cite experimental evidence (PubMed 38382015), supporting choice B.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> A knowledgeable model can recognize this 383-aa bacterial sequence as consistent with the UDP-GlcNAc 2-epimerase family. Enzymes of this family interconvert nucleotide sugars, producing a precursor used in bacterial capsule-polysaccharide synthesis. That family-level function points to capsule biogenesis (B), rather than ubiquitination, plant ajmaline biosynthesis, or iron-sulfur cluster assembly.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The offered choices are biologically distinct, and transferable sequence-family knowledge gives a meaningful basis to select capsule biogenesis without recalling this exact protein's database entry. The inference is not equivalent to experimental confirmation of this particular protein's role.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The capsule-polysaccharide pathway is the clearly best-fitting offered choice; the other options concern unrelated processes.


### Important caveats

- The reviewer-only record supports the key but was not part of the original input.
- The sequence-based family and pathway inference is probabilistic; the direct support for this protein's pathway association comes from the cited experimental annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A knowledgeable model can recognize this 383-aa bacterial sequence as consistent with the UDP-GlcNAc 2-epimerase family. Enzymes of this family interconvert nucleotide sugars, producing a precursor used in bacterial capsule-polysaccharide synthesis. That family-level function points to capsule biogenesis (B), rather than ubiquitination, plant ajmaline biosynthesis, or iron-sulfur cluster assembly.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The offered choices are biologically distinct, and transferable sequence-family knowledge gives a meaningful basis to select capsule biogenesis without recalling this exact protein's database entry. The inference is not equivalent to experimental confirmation of this particular protein's role."
  },
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record identifies the protein as UDP-N-acetylglucosamine 2-epimerase and annotates its pathway as capsule biogenesis/capsule polysaccharide biosynthesis. The enzyme annotation and pathway claim cite experimental evidence (PubMed 38382015), supporting choice B."
  },
  "important_caveats": [
    "The reviewer-only record supports the key but was not part of the original input.",
    "The sequence-based family and pathway inference is probabilistic; the direct support for this protein's pathway association comes from the cited experimental annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The capsule-polysaccharide pathway is the clearly best-fitting offered choice; the other options concern unrelated processes."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record identifies the protein as UDP-N-acetylglucosamine 2-epimerase and annotates its pathway as capsule biogenesis/capsule polysaccharide biosynthesis. The enzyme annotation and pathway claim cite experimental evidence (PubMed 38382015), supporting choice B.",
    "evidence_ids": ["C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "A knowledgeable model can recognize this 383-aa bacterial sequence as consistent with the UDP-GlcNAc 2-epimerase family. Enzymes of this family interconvert nucleotide sugars, producing a precursor used in bacterial capsule-polysaccharide synthesis. That family-level function points to capsule biogenesis (B), rather than ubiquitination, plant ajmaline biosynthesis, or iron-sulfur cluster assembly.",
    "missing_item_specific_fact": "",
    "reason": "The offered choices are biologically distinct, and transferable sequence-family knowledge gives a meaningful basis to select capsule biogenesis without recalling this exact protein's database entry. The inference is not equivalent to experimental confirmation of this particular protein's role."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The capsule-polysaccharide pathway is the clearly best-fitting offered choice; the other options concern unrelated processes."
  },
  "important_caveats": [
    "The reviewer-only record supports the key but was not part of the original input.",
    "The sequence-based family and pathway inference is probabilistic; the direct support for this protein's pathway association comes from the cited experimental annotation."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (A0A0U3CEN8) explicitly annotates the pathway as 'Capsule biogenesis; capsule polysaccharide biosynthesis' with experimental evidence (ECO:0000269, PubMed:38382015). The protein is UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14), and the cited 2024 Biochemistry paper by Ghosh & Raushel directly demonstrates its role in producing UDP-ManNAc and CMP-Neu5Ac precursors for Campylobacter jejuni capsular polysaccharides. The sequence in the question matches the annotated entry exactly (SHA-256 confirmed).

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence (~383 aa) displays characteristic Rossmann-fold NAD(P)-binding motifs (e.g., 'VTGQHRQ' and 'VTGHRRE' patterns) that are hallmarks of the UDP-sugar 2-epimerase / GalE-like family. This family is well-known from E. coli GalE, Neisseria, and other bacterial systems to function in sugar-nucleotide metabolism feeding into surface polysaccharide (capsule, LPS, exopolysaccharide) biosynthesis. Among the four options: (A) Protein ubiquitination involves E1/E2/E3 enzymes with UBC (~150 aa), RING, or HECT domains—none present here. (C) Ajmaline biosynthesis is a plant (Rauwolfia) alkaloid pathway relying on tryptophan decarboxylase, strictosidine synthase, and P450s—structurally and taxonomically incompatible with this prokaryotic NAD-dependent epimerase. (D) Iron-sulfur cluster biosynthesis involves cysteine desulfurases (PLP-dependent IscS), scaffold proteins (IscU), and Fe-S transfer proteins with entirely different folds. The Rossmann-fold epimerase architecture specifically points to sugar-nucleotide interconversion, which among the offered choices maps uniquely to capsule biogenesis (B).


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A model recognizing the NAD-binding Rossmann-fold motifs and the UDP-sugar 2-epimerase family from training on E. coli GalE, Neisseria CneA, and other homologs can connect this enzyme class to bacterial surface polysaccharide/capsule biosynthesis. The three distractors (ubiquitination, plant alkaloid biosynthesis, Fe-S cluster assembly) involve structurally and mechanistically unrelated protein families, making them distinguishable by family-level inference without needing the specific Campylobacter annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four choices span fundamentally different pathway types (ubiquitin-proteasome, bacterial capsule, plant alkaloid, Fe-S cluster assembly). The Rossmann-fold NAD-dependent epimerase motifs are incompatible with the domain architectures of all three distractors, leaving only capsule biogenesis as a consistent assignment.


### Important caveats

- The UniProt pathway annotation is backed by experimental evidence (ECO:0000269), not merely computational transfer, strengthening the key.
- The specific assignment to 'Capsule biogenesis' rather than a broader 'sugar nucleotide metabolism' label depends on knowing that in Campylobacter this epimerase feeds capsule polysaccharide precursors; however, among the four offered choices, capsule biogenesis is the only sugar-nucleotide-related pathway, so the family-level inference suffices.
- The reviewer-only evidence confirms sequence identity (SHA-256 match) and that the pathway annotation predates the benchmark cutoff (entry version 19, released Jan 2026).

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence (~383 aa) displays characteristic Rossmann-fold NAD(P)-binding motifs (e.g., 'VTGQHRQ' and 'VTGHRRE' patterns) that are hallmarks of the UDP-sugar 2-epimerase / GalE-like family. This family is well-known from E. coli GalE, Neisseria, and other bacterial systems to function in sugar-nucleotide metabolism feeding into surface polysaccharide (capsule, LPS, exopolysaccharide) biosynthesis. Among the four options: (A) Protein ubiquitination involves E1/E2/E3 enzymes with UBC (~150 aa), RING, or HECT domains—none present here. (C) Ajmaline biosynthesis is a plant (Rauwolfia) alkaloid pathway relying on tryptophan decarboxylase, strictosidine synthase, and P450s—structurally and taxonomically incompatible with this prokaryotic NAD-dependent epimerase. (D) Iron-sulfur cluster biosynthesis involves cysteine desulfurases (PLP-dependent IscS), scaffold proteins (IscU), and Fe-S transfer proteins with entirely different folds. The Rossmann-fold epimerase architecture specifically points to sugar-nucleotide interconversion, which among the offered choices maps uniquely to capsule biogenesis (B).",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A model recognizing the NAD-binding Rossmann-fold motifs and the UDP-sugar 2-epimerase family from training on E. coli GalE, Neisseria CneA, and other homologs can connect this enzyme class to bacterial surface polysaccharide/capsule biosynthesis. The three distractors (ubiquitination, plant alkaloid biosynthesis, Fe-S cluster assembly) involve structurally and mechanistically unrelated protein families, making them distinguishable by family-level inference without needing the specific Campylobacter annotation."
  },
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "C6",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (A0A0U3CEN8) explicitly annotates the pathway as 'Capsule biogenesis; capsule polysaccharide biosynthesis' with experimental evidence (ECO:0000269, PubMed:38382015). The protein is UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14), and the cited 2024 Biochemistry paper by Ghosh & Raushel directly demonstrates its role in producing UDP-ManNAc and CMP-Neu5Ac precursors for Campylobacter jejuni capsular polysaccharides. The sequence in the question matches the annotated entry exactly (SHA-256 confirmed)."
  },
  "important_caveats": [
    "The UniProt pathway annotation is backed by experimental evidence (ECO:0000269), not merely computational transfer, strengthening the key.",
    "The specific assignment to 'Capsule biogenesis' rather than a broader 'sugar nucleotide metabolism' label depends on knowing that in Campylobacter this epimerase feeds capsule polysaccharide precursors; however, among the four offered choices, capsule biogenesis is the only sugar-nucleotide-related pathway, so the family-level inference suffices.",
    "The reviewer-only evidence confirms sequence identity (SHA-256 match) and that the pathway annotation predates the benchmark cutoff (entry version 19, released Jan 2026)."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four choices span fundamentally different pathway types (ubiquitin-proteasome, bacterial capsule, plant alkaloid, Fe-S cluster assembly). The Rossmann-fold NAD-dependent epimerase motifs are incompatible with the domain architectures of all three distractors, leaving only capsule biogenesis as a consistent assignment."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0078",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (A0A0U3CEN8) explicitly annotates the pathway as 'Capsule biogenesis; capsule polysaccharide biosynthesis' with experimental evidence (ECO:0000269, PubMed:38382015). The protein is UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14), and the cited 2024 Biochemistry paper by Ghosh & Raushel directly demonstrates its role in producing UDP-ManNAc and CMP-Neu5Ac precursors for Campylobacter jejuni capsular polysaccharides. The sequence in the question matches the annotated entry exactly (SHA-256 confirmed).",
    "evidence_ids": ["C5", "C4", "C6", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence (~383 aa) displays characteristic Rossmann-fold NAD(P)-binding motifs (e.g., 'VTGQHRQ' and 'VTGHRRE' patterns) that are hallmarks of the UDP-sugar 2-epimerase / GalE-like family. This family is well-known from E. coli GalE, Neisseria, and other bacterial systems to function in sugar-nucleotide metabolism feeding into surface polysaccharide (capsule, LPS, exopolysaccharide) biosynthesis. Among the four options: (A) Protein ubiquitination involves E1/E2/E3 enzymes with UBC (~150 aa), RING, or HECT domains—none present here. (C) Ajmaline biosynthesis is a plant (Rauwolfia) alkaloid pathway relying on tryptophan decarboxylase, strictosidine synthase, and P450s—structurally and taxonomically incompatible with this prokaryotic NAD-dependent epimerase. (D) Iron-sulfur cluster biosynthesis involves cysteine desulfurases (PLP-dependent IscS), scaffold proteins (IscU), and Fe-S transfer proteins with entirely different folds. The Rossmann-fold epimerase architecture specifically points to sugar-nucleotide interconversion, which among the offered choices maps uniquely to capsule biogenesis (B).",
    "missing_item_specific_fact": "",
    "reason": "A model recognizing the NAD-binding Rossmann-fold motifs and the UDP-sugar 2-epimerase family from training on E. coli GalE, Neisseria CneA, and other homologs can connect this enzyme class to bacterial surface polysaccharide/capsule biosynthesis. The three distractors (ubiquitination, plant alkaloid biosynthesis, Fe-S cluster assembly) involve structurally and mechanistically unrelated protein families, making them distinguishable by family-level inference without needing the specific Campylobacter annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four choices span fundamentally different pathway types (ubiquitin-proteasome, bacterial capsule, plant alkaloid, Fe-S cluster assembly). The Rossmann-fold NAD-dependent epimerase motifs are incompatible with the domain architectures of all three distractors, leaving only capsule biogenesis as a consistent assignment."
  },
  "important_caveats": [
    "The UniProt pathway annotation is backed by experimental evidence (ECO:0000269), not merely computational transfer, strengthening the key.",
    "The specific assignment to 'Capsule biogenesis' rather than a broader 'sugar nucleotide metabolism' label depends on knowing that in Campylobacter this epimerase feeds capsule polysaccharide precursors; however, among the four offered choices, capsule biogenesis is the only sugar-nucleotide-related pathway, so the family-level inference suffices.",
    "The reviewer-only evidence confirms sequence identity (SHA-256 match) and that the pathway annotation predates the benchmark cutoff (entry version 19, released Jan 2026)."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A0U3CEN8",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "ddbc20d90a4cb51741fc357432ae609ce704ff3086e52fc8f54e4db1b9cd9037",
  "benchmark_sequence_length": 383,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 21,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2016-03-16",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "79cec39f8af13d58c2f3eacbeec9904c65a82d2ceedf2c1bacc9916abbc9faf0",
  "current_source_sequence_sha256": "ddbc20d90a4cb51741fc357432ae609ce704ff3086e52fc8f54e4db1b9cd9037",
  "current_source_sequence_length": 383,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 19,
  "selected_historical_version": {
    "accession": "A0A0U3CEN8",
    "database": "Swiss-Prot",
    "entryVersion": 19,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "UAGEP_CAMJU",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "ab154b9f6d4f7d6da6b610c345b588d7236e7842a8415b0bb9cb9fac2fce5141",
  "selected_historical_source_sequence_sha256": "ddbc20d90a4cb51741fc357432ae609ce704ff3086e52fc8f54e4db1b9cd9037",
  "selected_historical_source_sequence_length": 383,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 19,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json",
  "source_sha256": "79cec39f8af13d58c2f3eacbeec9904c65a82d2ceedf2c1bacc9916abbc9faf0",
  "retrieved_utc": "2026-11-02T04:24:21.799773+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A0U3CEN8\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json",
  "source_sha256": "79cec39f8af13d58c2f3eacbeec9904c65a82d2ceedf2c1bacc9916abbc9faf0",
  "retrieved_utc": "2026-11-02T04:24:21.799773+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":21,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2016-03-16\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json",
  "source_sha256": "79cec39f8af13d58c2f3eacbeec9904c65a82d2ceedf2c1bacc9916abbc9faf0",
  "retrieved_utc": "2026-11-02T04:24:21.799773+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Campylobacterota\",\"Epsilonproteobacteria\",\"Campylobacterales\",\"Campylobacteraceae\",\"Campylobacter\"],\"scientificName\":\"Campylobacter jejuni\",\"taxonId\":197}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json",
  "source_sha256": "79cec39f8af13d58c2f3eacbeec9904c65a82d2ceedf2c1bacc9916abbc9faf0",
  "retrieved_utc": "2026-11-02T04:24:21.799773+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"38382015\",\"source\":\"PubMed\"}],\"value\":\"Non-hydrolyzing UDP-GlcNAc 2-epimerase\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"38382015\",\"source\":\"PubMed\"}],\"value\":\"5.1.3.14\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"UDP-N-acetylglucosamine 2-epimerase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json",
  "source_sha256": "79cec39f8af13d58c2f3eacbeec9904c65a82d2ceedf2c1bacc9916abbc9faf0",
  "retrieved_utc": "2026-11-02T04:24:21.799773+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"38382015\",\"source\":\"PubMed\"}],\"value\":\"Capsule biogenesis; capsule polysaccharide biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0U3CEN8.json",
  "source_sha256": "79cec39f8af13d58c2f3eacbeec9904c65a82d2ceedf2c1bacc9916abbc9faf0",
  "retrieved_utc": "2026-11-02T04:24:21.799773+00:00",
  "json_pointer": "/references/2",
  "excerpt": "{\"citation\":{\"authors\":[\"Ghosh M.K.\",\"Raushel F.M.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"38382015\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.biochem.3c00664\"}],\"citationType\":\"journal article\",\"firstPage\":\"688\",\"id\":\"38382015\",\"journal\":\"Biochemistry\",\"lastPage\":\"698\",\"publicationDate\":\"2024\",\"title\":\"Biosynthesis of UDP-alpha-N-Acetyl-d-mannosaminuronic Acid and CMP-beta-N-Acetyl-d-neuraminic Acid for the Capsular Polysaccharides of Campylobacter jejuni.\",\"volume\":\"63\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"HS:11\"}],\"referenceNumber\":3,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0U3CEN8?format=txt&versions=19)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0U3CEN8?format=txt&versions=19",
  "source_sha256": "ab154b9f6d4f7d6da6b610c345b588d7236e7842a8415b0bb9cb9fac2fce5141",
  "retrieved_utc": "2026-11-02T04:24:23.855684+00:00",
  "source_locator": "lines 1-13",
  "excerpt": "ID   UAGEP_CAMJU             Reviewed;         383 AA.\nAC   A0A0U3CEN8;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   16-MAR-2016, sequence version 1.\nDT   28-JAN-2026, entry version 19.\nDE   RecName: Full=UDP-N-acetylglucosamine 2-epimerase {ECO:0000305};\nDE            EC=5.1.3.14 {ECO:0000269|PubMed:38382015};\nDE   AltName: Full=Non-hydrolyzing UDP-GlcNAc 2-epimerase {ECO:0000303|PubMed:38382015};\nGN   Name=HS11.17 {ECO:0000303|PubMed:38382015};\nOS   Campylobacter jejuni.\nOC   Bacteria; Pseudomonadati; Campylobacterota; Epsilonproteobacteria;\nOC   Campylobacterales; Campylobacteraceae; Campylobacter.\nOX   NCBI_TaxID=197;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 19,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0U3CEN8?format=txt&versions=19)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0U3CEN8?format=txt&versions=19",
  "source_sha256": "ab154b9f6d4f7d6da6b610c345b588d7236e7842a8415b0bb9cb9fac2fce5141",
  "retrieved_utc": "2026-11-02T04:24:23.855684+00:00",
  "source_locator": "lines 29-37",
  "excerpt": "RN   [3]\nRP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.\nRC   STRAIN=HS:11;\nRX   PubMed=38382015; DOI=10.1021/acs.biochem.3c00664;\nRA   Ghosh M.K., Raushel F.M.;\nRT   \"Biosynthesis of UDP-alpha-N-Acetyl-d-mannosaminuronic Acid and CMP-beta-N-\nRT   Acetyl-d-neuraminic Acid for the Capsular Polysaccharides of Campylobacter\nRT   jejuni.\";\nRL   Biochemistry 63:688-698(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 19,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0U3CEN8?format=txt&versions=19)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0U3CEN8?format=txt&versions=19",
  "source_sha256": "ab154b9f6d4f7d6da6b610c345b588d7236e7842a8415b0bb9cb9fac2fce5141",
  "retrieved_utc": "2026-11-02T04:24:23.855684+00:00",
  "source_locator": "lines 54-55",
  "excerpt": "CC   -!- PATHWAY: Capsule biogenesis; capsule polysaccharide biosynthesis.\nCC       {ECO:0000269|PubMed:38382015}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 19,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 78. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
